+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Aspirin for primary prevention of cardiovascular events in people with diabetes



Aspirin for primary prevention of cardiovascular events in people with diabetes



Journal of the American College of Cardiology 55(25): 2878-2886




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051647824

Download citation: RISBibTeXText

PMID: 20579547

DOI: 10.1016/j.jacc.2010.04.003


Related references

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. Bmj 339: B4531, 2009

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials 8(): 21-21, 2007

Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study. Medical Journal of Australia 189(2): 105-109, 2008

Aspirin for primary prevention of cardiovascular events in diabetes. Diabetes Care 26(12): 3349-3350, 2003

Primary Prevention of Cardiovascular Events With Aspirin in Patients With Diabetes. Diabetes Spectrum 24(1): 47-49, 2011

Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes?. Medical Journal of Australia 190(11): 614-615, 2009

Aspirin for primary prevention of cardiovascular events in diabetes: still an open question. JAMA 300(18): 2180-2181, 2008

Aspirin for primary prevention of cardiovascular disease events in diabetes: the balancing act?. Journal of the Royal College of Physicians of Edinburgh 48(4): 332-333, 2018

Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis. Diabetes Research and Clinical Practice 87(2): 211-218, 2010

Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. American Journal of the Medical Sciences 341(1): 1-9, 2011

Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?. Diabetes and Metabolism 44(3): 217-225, 2017

Erratum. Aspirin for the Primary Prevention of Cardiovascular Events. A Systematic Review and Meta-Analysis Comparing Patients With and Without Diabetes. Diabetes Care 2009;32:2300-2306. Diabetes Care: -, 2018

Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes. Diabetes Care 32(12): 2300-2306, 2010

Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials. Diabetic Medicine 34(3): 316-327, 2016

Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials. Thrombosis and Haemostasis 104(6): 1085-1088, 2011